Related Experiment Videos
Clinical outcomes after transfusion-associated hepatitis C
M J Tong1, N S el-Farra, A R Reikes
1Liver Center, Huntington Memorial Hospital, Pasadena, CA 91105, USA.
The New England Journal of Medicine
|June 1, 1995
Summary
Chronic hepatitis C infection acquired from blood transfusions can lead to serious liver complications and death. This progressive disease requires careful monitoring for conditions like cirrhosis and liver cancer.
Area of Science:
- Hepatology
- Transfusion Medicine
- Infectious Diseases
Background:
- The long-term consequences of chronic hepatitis C infection following blood transfusions are not well-defined.
- Understanding these complications is crucial for patient management and public health.
Purpose of the Study:
- To investigate the clinical course and serious complications of chronic hepatitis C infection acquired through blood transfusions.
- To assess the progression of liver disease and mortality in this patient cohort.
Main Methods:
- A cohort of 131 patients with chronic post-transfusion hepatitis C was studied.
- Patients with confounding liver conditions or risk factors were excluded.
- Liver biopsies were performed on 101 patients, with clinical assessment for the remainder.
Main Results:
- The study cohort had a mean age of 57 years, with a mean follow-up of 3.9 years.
- Hepatomegaly and fatigue were common initial symptoms.
- Significant progression to cirrhosis (51.1%) and hepatocellular carcinoma (5.3% initially, with more developing later) was observed.
- Mortality was 15.3%, primarily due to cirrhosis complications and hepatocellular carcinoma.
Conclusions:
- Chronic hepatitis C infection acquired via blood transfusion is a progressive liver disease.
- It can lead to severe outcomes, including liver failure and hepatocellular carcinoma.
- This underscores the importance of screening blood products and managing infected individuals.